Imiquimod 2HCl
- CAS No.
- 2995277-02-4
- Chemical Name:
- Imiquimod 2HCl
- Synonyms
- Imiquimod 2HCl;1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-, hydrochloride (1:2)
- CBNumber:
- CB114698898
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Imiquimod 2HCl Chemical Properties,Uses,Production
Uses
Imiquimod (R 837) dihydrochloride, an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19[1][2].
in vivo
Imiquimod (IMQ) can be used to induce psoriasis models[5].
Administration: 3.125 mg/day ? skin ? 6 days
(1) Prepare BM of lipids
STA and OA were melted at 75 °C followed by the addition of IMQ (3.5% of the BM, w/w) under continuous stirring.
Polysorbate 80 and stearoyl polyoxyl-32 glycerides at a 50:50 ratio were dispersed in water heated separately to 75 °C and added to the BM phase under continuous stirring.
(2) Prepare nanostructured lipid carriers (NLCs)
The mixture was then subjected to high-shear homogenization followed by ultrasonication.
The mixture was then rapidly cooled in an ice bath to allow the formation of NLCs.
Resulted in hyperproliferative keratinocytes and a disturbed epidermal differentiation (parakeratosis).
[1].
References
[1] Athina Angelopoulou, et al. Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19. Environ Res. 2020 Sep; 188: 109858. DOI:10.1016/j.envres.2020.109858
[2] Aditya K Gupta, et al. Imiquimod: a review. J Cutan Med Surg. Nov-Dec 2002;6(6):554-60. DOI:10.1007/s10227-001-0134-6
[3] Yuji Kan, et al. Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway. J Virol. 2012 Oct;86(19):10338-46. DOI:10.1128/JVI.01196-12
[4] Michael P Sch?n, et al. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol. 2006 Jun;126(6):1338-47. DOI:10.1038/sj.jid.5700286
[5] Leslie van der Fits, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009, 182, 9. DOI:10.4049/jimmunol.0802999
[6] Ajla Smajlovi?, et al. Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments. Mol Biol Rep. 2021, 48, 5. DOI:10.1007/s11033-021-06445-3
[7] Sangseo Kim, et al. Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach. Int J Nanomedicine. 2023. DOI:10.2147/IJN.S400610
Imiquimod 2HCl Preparation Products And Raw materials
Raw materials
Preparation Products
Imiquimod 2HCl Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32436 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39035 | 58 |
| TargetMol Chemicals Inc. | +17819995354 | marketing@targetmol.com | United States | 19961 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29342 | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 18916360931 18916360931 | 2596183085@qq.com | China | 17236 | 58 |
| Supplier | Advantage |
|---|---|
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 58 |
View Lastest Price from Imiquimod 2HCl manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2025-12-16 | Imiquimod 2HCl
2995277-02-4
|
US $195.00-692.00 / mg | 99.41% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-12-16 | Imiquimod 2HCl
2995277-02-4
|
US $195.00-692.00 / mg | 99.41% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-05-15 | Imiquimod 2HCl
2995277-02-4
|
US $195.00-692.00 / mg | 99.18% | 10g | TargetMol Chemicals Inc. |
-

- Imiquimod 2HCl
2995277-02-4
- US $195.00-692.00 / mg
- 99.41%
- TargetMol Chemicals Inc.
-

- Imiquimod 2HCl
2995277-02-4
- US $195.00-692.00 / mg
- 99.41%
- TargetMol Chemicals Inc.
-

- Imiquimod 2HCl
2995277-02-4
- US $195.00-692.00 / mg
- 99.18%
- TargetMol Chemicals Inc.




